That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
Breaking news headlines, stories and live updates on current affairs from across the globe. Complete coverage on the latest ...
The biotech company said the FDA won't review its flu vaccine, in the latest hit to mRNA development As COVID-19 vaccine sales dwindle, pressure on Moderna to grow its business has increased.
Scientists could soon develop personalized cancer vaccines.
The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the ...
(Reuters) - Moderna Inc said on Wednesday its experimental COVID-19 vaccine induced immune responses in older adults similar to those in younger participants, offering hope that it will be effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results